Sildenafil Tablet
Product Images NDC 65162-351

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 65162-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tablets 20mg 1

Sildenafil Tablets 20mg 1
This is a table with three columns and three rows. The first column contains text indicating the level of dosage (High, Medium, and Low), the second column has a numerical value for each dosage level (37, 30, and 25 respectively), and the third column appears to be cut off, so its content is not available. It is unclear what medication or substance these dosages refer to.*
FDA Label Image

Sildenafil Tablets 20mg 10

Sildenafil Tablets 20mg 10
This is a description for Sildenafil tablets, USP. Each film-coated tablet contains Sildenafil citrate, USP equivalent to 20 mg sildenafil. It is an Rx-only drug that comes in a pack of 1,000 tablets. Users are advised to see accompanying prescription information before use. The medicine should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15" to 30°C (59° to 86°F). The drug is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
FDA Label Image

Sildenafil Tablets 20mg 2

FDA Label Image

Sildenafil Tablets 20mg 3

Sildenafil Tablets 20mg 3
This text appears to be a guide for healthcare professionals regarding the recommended dose adjustments for various drugs when taken together with sildenafil. The table presents data with drug names and their respective AUC, Cmax and dose effect interactions. Also, it mentions that no dose adjustment is needed for some of the drugs when taken together with sildenafil like Alorsaan, Smromye, Hasoxe and oral contraceptives. The guide also makes note of the accumulation of the AUC ratio from Day 1 to Day 7 relative to sildenafil alone for Bosentan. Lastly, it is recommended not to coadminister Ritonavir with sildenafil as it may have an effect on AUC and Cmax.*
FDA Label Image

Sildenafil Tablets 20mg 4

Sildenafil Tablets 20mg 4
This text appears to be a list of drugs and their interaction with Acenocoumarol. It shows the effect of co-administration on parameters such as AUC and Cmax. The text also provides recommendations for dose adjustments, if any, and cautions against co-administration in some cases. The last sentence mentions the effect of Ritonavir on Sidenafil PK.*
FDA Label Image

Sildenafil Tablets 20mg 5

FDA Label Image

Sildenafil Tablets 20mg 6

FDA Label Image

Sildenafil Tablets 20mg 7

FDA Label Image

Sildenafil Tablets 20mg 8

FDA Label Image

Sildenafil Tablets 20mg 9

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.